We have noted that US health care has been taken over by generic managers . A recent article about the CEOs of purportedly some of America...
07.54.00
CHF
clinical trials
Entresto
evidence-based medicine
manipulating clinical research
Novartis
sacubitril
Entresto: Blockbuster, or Just Over Hyped? - Whatever, It Will Cost $4500 a Year
The newest drug for congestive heart failure, Entresto, a fixed combination of valsartan and sacubitril, has just hit the market at an eleva...
What They Really Think of Us, UK Version - Health Secretary Derides NHS Doctors for Not Working Enough on Weekends
A new story from the UK suggests what top leaders of health care really think about health care professionals. I realize that I risk showin...
Turn, Turn, Turn - from Columbia/ HCA Executive, to Virginia Secretary of Health and Human Resources, to Director of the Center for Medicare and Medicaid Services (CMS), to America's Healt Insurance Plans (AHIP)
Marilyn Tavenner's career continues to revolve, er, evolve. Columbia/ HCA Marilyn Tavenner worked for Columbia / HCA, now HCA, although ...
18.29.00
boards of directors
conflicts of interest
executive compensation
mission-hostile management
Mylan
perverse incentives
Who Benefits? - Rising Generic Drug Prices and the Case of Mylan's Conflicted Property Purchases
Rising Generic Drug Prices Health care costs in the US continue their seemingly inexorable rise. Even the parts of health care that used to...
Bill Clinton, Paid to Speak to Biotech Conference, Extolled $1000 Pill to Prevent "Liver Rot," Despite Lack of Evidence that It Does
What were they thinking? Former President Clinton Talkes to Pharma and Biotech Executives In mid June, 2015, the Philadelphia Inquirer repor...
Langganan:
Postingan (Atom)